(Date:11/24/2009)...SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxya...n(SFDA)hasapprovedthe,investigationalnewdrugapplic...vativeinsulinformulationtotreatdiabetes.ThisIND,ap...lstudy. , Diabetesisadisordercharacteristicof...sofdiabetesoftenresultinseveremicro-and,macro-vasc...
(Date:11/24/2009)... The FBI recently approved the Pr...es participating in or generating DNA records for ... Madison, WI USA (PRWEB) -- The FBI recentl...m for use by laboratories participating in, or ge...ystem (NDIS). NDIS currently contains more than se...
(Date:11/24/2009)...TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswire-Fi...ottoCapitalInc.,aleadingproviderofadvancedlasersys...tyclinicmarkets,todayreportedoperationalandfinanci..., ,Q32009Highlights,-Revenuewas$1.46millioncompa...6.3percentcomparedwith66.1percentinQ3,2008,-Netlos...
(Date:11/24/2009)...SANDIEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaP...thatthecompanyisscheduledtopresentatthePiperJaffra...1:30a.m.EasternTime(8:30a.m.PacificTime)attheNewYo...ent andChiefExecutiveOfficer,isscheduledtoprovidea...entanddiscoveryprograms. ,, Aliveaudiowebcastof...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2...ceutical Communication Event, Where Executives Ga...R &, Communications Summit for Pharmaceutical, Bi... Companies, NEW YORK, May 29 ExL Pharma ...e the participation of two keynote speakers from t...uring the 4th Annual Public,Relations and Communic...
...idates the critical role of self-care in...May 29 InterCure Ltd., a medical device,company p...E: INCR), today,announced its support of the new j...Association, American Society of Hypertension and ...declaring that people with,hypertension should rou...
...nch of Nine Emerging Therapies, Including Five Or... Resources, WALTHAM...rld,s leading research and advisory firms for phar...ighly anticipated launch of the first,oral agents ...e market,growth as these therapies, combined, will...
Other Biology Technology:FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications 2FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications 3InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring 2InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring 3Oral Drug From Novartis/Mitsubishi Tanabe Will Capture the Largest Market Share of All Emerging Multiple Sclerosis Therapies in 2017 2Mouse Anti-Plastin L Monoclonal Antibody, Unconjugated, Clone LPL4A.1 from Abcam
HyperMu Transposon from EPICENTRE Biotechnologies
Rhesus Macaque IFN-alpha from R&D Systems
Sheep Anti-chk 1 kinase Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Biology Products: